EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

H3F3B gene mutation in chondroblastomas: a multicenter study

İlkay Tosun iD, İsmail Yılmaz iD, Aslı Çakır iD, Cem Çomunoğlu iD, Kemal Türköz iD, Nil Çomunoğlu iD, Sibel Çetinkaya iD, Hande Nur İnceman iD, Gökçen Ünverengil iD

Acta Orthopaedica et Traumatologica Turcica · 31.07.2026 · 60 (4)

DOI: 10.5152/j.aott.2026.25277 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, online erschienen am 31.07.2026. Verfasst von İlkay Tosun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ümraniye Training and Research Hospital, Health Sciences University, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Chondroblastoma, Bone Neoplasms, Mutation, Histones. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chondroblastoma (CB) is a benign but locally aggressive bone tumor that may present histopathologic diagnostic challenges, particularly in atypical locations and limited biopsy specimens. Recent studies have identified recurrent mutations in the H3F3B and, less frequently, H3F3A genes, suggesting their potential diagnostic value. This study aimed to evaluate the prevalence and diagnostic utility of H3F3A and H3F3B mutations in a multicenter cohort of CB patients.

Methods

Forty-three patients with histopathologically confirmed CB were included in a retrospective analysis. All cases were re-evaluated by 2 pathologists, and mutation analysis of H3F3A and H3F3B genes was performed using polymerase chain reaction–based Sanger sequencing.

Results

H3F3B mutations were detected in 41 cases (95.3%), all corresponding to the Lys36Met substitution. One case (2.3%) harbored an H3F3A Gly34Trp mutation, whereas 1 case (2.3%) showed no detectable mutation. No significant histopathological differences were observed between mutation-positive and mutation-negative cases. A notable case involved a 72-year-old patient with frontal bone involvement, highlighting the diagnostic difficulty in unusual locations and older age groups.

Conclusion

The findings demonstrate that H3F3B mutation analysis is an extremely sensitive and reliable molecular tool for confirming the diagnosis of CB. It is particularly valuable in challenging cases and especially in small biopsy samples where pathognomonic findings, such as chicken-wire calcification and chondroid matrix are not visible. Incorporation of molecular testing into targeted diagnostic workflows may improve diagnostic accuracy and assist in distinguishing CB from its histological mimics. Cite this article as: Tosun I, Yilmaz I, Cakir A, et al. H3F3B gene mutation in chondroblastomas: a multicenter study. Acta Orthop Traumatol Turc.,2026; 60(4), 0277, doi: 10.5152/j.aott.2026.25277.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondroblastomaBone NeoplasmsMutationHistonesHumansFemaleMaleRetrospective StudiesDNA Mutational AnalysisAgedMiddle AgedAdultAdolescent

Stichwörter der Autor:innen

Bone tumorChondroblastomaH3F3AH3F3BMutation

Substanzen

HistonesH3-3A protein, human

Autor:innen und Institutionen

  • Department of Pathology, Ümraniye Training and Research Hospital, Health Sciences University, İstanbul, Türkiye.
  • Department of Pathology, Sultan II Abdülhamit Han Training and Research Hospital, Health Sciences University, İstanbul, Türkiye.
  • Department of Pathology, Medical Faculty Hospital, Medipol University, İstanbul, Türkiye.
  • Department of Pathology, Okmeydanı Training and Research Hospital, Health Sciences University, İstanbul, Türkiye.
  • Department of Pathology, Pendik Training and Research Hospital, Marmara University, İstanbul, Türkiye.
  • Department of Pathology, Cerrahpaşa Medical Faculty, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.

ORCID-Profile: İlkay Tosun, İsmail Yılmaz, Aslı Çakır, Cem Çomunoğlu, Kemal Türköz, Nil Çomunoğlu, Sibel Çetinkaya, Hande Nur İnceman, Gökçen Ünverengil

Zitieren

APA

Tosun, İ., Yılmaz, İ., Çakır, A., Çomunoğlu, C., Türköz, K., Çomunoğlu, N., Çetinkaya, S., İnceman, H. N., & Ünverengil, G. (2026). H3F3B gene mutation in chondroblastomas: a multicenter study. Acta Orthopaedica et Traumatologica Turcica, 60(4). https://doi.org/10.5152/j.aott.2026.25277

Vancouver

Tosun İ, Yılmaz İ, Çakır A, Çomunoğlu C, Türköz K, Çomunoğlu N, et al. H3F3B gene mutation in chondroblastomas: a multicenter study. Acta Orthopaedica et Traumatologica Turcica. 2026;60(4). doi:10.5152/j.aott.2026.25277

BibTeX
@article{Tosun2026,
  author = {Tosun, İlkay and Yılmaz, İsmail and Çakır, Aslı and Çomunoğlu, Cem and Türköz, Kemal and Çomunoğlu, Nil and Çetinkaya, Sibel and İnceman, Hande Nur and Ünverengil, Gökçen},
  title = {H3F3B gene mutation in chondroblastomas: a multicenter study},
  journal = {Acta Orthopaedica et Traumatologica Turcica},
  year = {2026},
  volume = {60},
  number = {4},
  doi = {10.5152/j.aott.2026.25277}
}
Kostenlos starten →